Waldencast PLC
WALD1.480USD
+0.010+0.68%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
167.32MMarket Cap
LossP/E TTM
More Details of Waldencast PLC Company
Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
Waldencast PLC Info
Ticker SymbolWALD
Company nameWaldencast PLC
IPO dateMar 18, 2021
CEOBrousset (Michel)
Number of employees332
Security typeOrdinary Share
Fiscal year-endMar 18
AddressMichelin House, 81 Fulham Road
CityLONDON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited Kingdom
Postal codeSW3 6RD
Phone442031960264
Websitehttps://www.waldencast.com/
Ticker SymbolWALD
IPO dateMar 18, 2021
CEOBrousset (Michel)
Company Executives of Waldencast PLC
Name
Name/Position
Position
Shareholding
Change
Mr. Michel Brousset
Mr. Michel Brousset
Chief Executive Officer, Director
Chief Executive Officer, Director
2.90M
--
Ms. Hind Sebti
Ms. Hind Sebti
Chief Growth Officer, Director
Chief Growth Officer, Director
20.00K
--
Mr. Aaron Chatterley
Mr. Aaron Chatterley
Independent Director
Independent Director
20.00K
--
Ms. Juliette Hickman
Ms. Juliette Hickman
Independent Director
Independent Director
20.00K
--
Ms. Lindsay Pattison
Ms. Lindsay Pattison
Independent Director
Independent Director
20.00K
--
Mr. Felipe Dutra
Mr. Felipe Dutra
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Cristiano Souza
Mr. Cristiano Souza
Director
Director
--
--
Mr. Zachary (Zack) Werner
Mr. Zachary (Zack) Werner
Independent Director
Independent Director
--
--
Mr. Simon Dailley
Mr. Simon Dailley
Director
Director
--
--
Mr. Manuel Manfredi
Mr. Manuel Manfredi
Chief Financial Officer
Chief Financial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michel Brousset
Mr. Michel Brousset
Chief Executive Officer, Director
Chief Executive Officer, Director
2.90M
--
Ms. Hind Sebti
Ms. Hind Sebti
Chief Growth Officer, Director
Chief Growth Officer, Director
20.00K
--
Mr. Aaron Chatterley
Mr. Aaron Chatterley
Independent Director
Independent Director
20.00K
--
Ms. Juliette Hickman
Ms. Juliette Hickman
Independent Director
Independent Director
20.00K
--
Ms. Lindsay Pattison
Ms. Lindsay Pattison
Independent Director
Independent Director
20.00K
--
Mr. Felipe Dutra
Mr. Felipe Dutra
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2023
FY2022
FY2022Q2
FY2022Q1
FY2021
FY2021Q4
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product sales
269.37M
98.36%
Royalties
4.50M
1.67%
By RegionUSD
Name
Revenue
Proportion
North America
202.26M
75.09%
Rest of the World
67.11M
24.91%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product sales
269.37M
98.36%
Royalties
4.50M
1.67%
Shareholding Stats
Updated: Fri, Dec 5
Updated: Fri, Dec 5
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cedarwalk Skincare Ltd
24.26%
Zeno Equity Partners LLP
10.38%
Arbitrage Ltd
8.47%
Waldencast Long-Term Capital LLC
7.89%
Burwell Mountain Trust
6.65%
Other
42.34%
Shareholders
Shareholders
Proportion
Cedarwalk Skincare Ltd
24.26%
Zeno Equity Partners LLP
10.38%
Arbitrage Ltd
8.47%
Waldencast Long-Term Capital LLC
7.89%
Burwell Mountain Trust
6.65%
Other
42.34%
Shareholder Types
Shareholders
Proportion
Corporation
51.85%
Hedge Fund
10.39%
Investment Advisor
7.43%
Private Equity
5.16%
Individual Investor
2.56%
Investment Advisor/Hedge Fund
1.51%
Bank and Trust
0.68%
Research Firm
0.10%
Pension Fund
0.01%
Other
20.32%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
139
29.82M
25.27%
-1.29M
2025Q3
137
33.43M
29.67%
-11.54M
2025Q2
146
93.35M
82.94%
-3.39K
2025Q1
148
93.02M
82.58%
-230.78K
2024Q4
144
78.12M
69.70%
-17.61M
2024Q3
135
86.17M
77.32%
-10.93M
2024Q2
172
87.50M
78.73%
-27.82M
2024Q1
176
82.86M
81.85%
-41.80M
2023Q4
166
82.66M
81.66%
-28.79M
2023Q3
155
85.92M
95.07%
-24.54M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Cedarwalk Skincare Ltd
28.64M
24.26%
--
--
Feb 28, 2025
Zeno Equity Partners LLP
12.25M
10.38%
-3.54M
-22.40%
Sep 30, 2025
Arbitrage Ltd
10.00M
8.47%
+10.00M
--
Feb 28, 2025
Waldencast Long-Term Capital LLC
9.31M
7.89%
--
--
Feb 28, 2025
Burwell Mountain Trust
7.85M
6.65%
--
--
Feb 28, 2025
Main Post Partners, L.P.
6.09M
5.16%
--
--
Feb 28, 2025
Annapurna Investment Fund Ltd.
5.40M
4.58%
+73.14K
+1.37%
Aug 15, 2025
Fitpart Fund Administration Services Ltd
3.45M
2.92%
+3.45M
--
Aug 15, 2025
Brousset (Michel)
2.90M
2.46%
--
--
Feb 28, 2025
Milestones Administradora de Recursos Ltda.
2.43M
2.06%
+225.68K
+10.26%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Russell 2000 Value ETF
0.01%
Global X Russell 2000 Covered Call ETF
0%
Avantis US Small Cap Equity ETF
0%
Global X Russell 2000 ETF
0%
ProShares Hedge Replication ETF
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Value ETF
Proportion0.01%
Global X Russell 2000 Covered Call ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 3000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Waldencast PLC?
The top five shareholders of Waldencast PLC are:
Cedarwalk Skincare Ltd holds 28.64M shares, accounting for 24.26% of the total shares.
Zeno Equity Partners LLP holds 12.25M shares, accounting for 10.38% of the total shares.
Arbitrage Ltd holds 10.00M shares, accounting for 8.47% of the total shares.
Waldencast Long-Term Capital LLC holds 9.31M shares, accounting for 7.89% of the total shares.
Burwell Mountain Trust holds 7.85M shares, accounting for 6.65% of the total shares.
Cedarwalk Skincare Ltd holds 28.64M shares, accounting for 24.26% of the total shares.
Zeno Equity Partners LLP holds 12.25M shares, accounting for 10.38% of the total shares.
Arbitrage Ltd holds 10.00M shares, accounting for 8.47% of the total shares.
Waldencast Long-Term Capital LLC holds 9.31M shares, accounting for 7.89% of the total shares.
Burwell Mountain Trust holds 7.85M shares, accounting for 6.65% of the total shares.
What are the top three shareholder types of Waldencast PLC?
The top three shareholder types of Waldencast PLC are:
Cedarwalk Skincare Ltd
Zeno Equity Partners LLP
Arbitrage Ltd
Cedarwalk Skincare Ltd
Zeno Equity Partners LLP
Arbitrage Ltd
How many institutions hold shares of Waldencast PLC (WALD)?
As of 2025Q4, 139 institutions hold shares of Waldencast PLC, with a combined market value of approximately 29.82M, accounting for 25.27% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -4.40%.
What is the biggest source of revenue for Waldencast PLC?
In FY2024, the Product sales business generated the highest revenue for Waldencast PLC, amounting to 269.37M and accounting for 98.36% of total revenue.
